Welcome to CDC Stacks | CDC Updates Interim Guidelines for Anthrax Exposure Management and Antimicrobial Therapy - 7178 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC Updates Interim Guidelines for Anthrax Exposure Management and Antimicrobial Therapy
Filetype[HTML - ]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Keywords:
  • Description:
    The Centers for Disease Control and Prevention (CDC) has issued an update on the investigation of recent cases of anthrax exposure. This update includes the susceptibility patterns of Bacillus anthracis isolates, and provides interim recommendations for managing potential threats and exposures and for treating anthrax. The complete report appears in the October 26, 2001 issue of Morbidity and Mortality Weekly Report and is available on the CDC Web site at www.cdc.gov/mmwr. A copy of the report is also available on the Web site of the American Academy of Family Physicians at www.aafp.org/resources.

  • Collection(s):
    Guidelines and Recommendations
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
    Source:
    MMWR. Morbidity and mortality weekly report. 2001; 50(42):909-19.
    Description:
    Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. This report updates previous findings, provides new information on case investigations in two additional areas, pr...
    Status:
    superseded
    File Type:
    Filetype[PDF - 212.95 KB]
  2. CDC Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women
    Corporate Author:
    National Center for Environmental Health (NCEH), CDC
    Description:
    Despite improvements in environmental policies and significant reductions in U.S. average blood lead levels,
    Status:
    current
    File Type:
    Filetype[PDF - 4.25 MB]
  3. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax
    Source:
    MMWR. Morbidity and mortality weekly report. 2001; 50(43):941-8.
    Description:
    Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. This report updates findings as of October 31, and includes interim guidelines for the clinical evaluation of pers...
    Status:
    superseded
    File Type:
    Filetype[PDF - 218.12 KB]
  4. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax
    Source:
    JAMA : the journal of the American Medical Association. 2001; 286(19):2392-6.
    Status:
    superseded
    File Type:
    Filetype[PDF - 104.01 KB]
  5. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis : 2005 CDC guidelines
    Personal Author:
    Tiwari, Tejpratap; Murphy, Trudy V.; Moran, John S.;
    Corporate Author:
    National Immunization Program (Centers for Disease Control and Prevention)
    Published:
    December 9, 2005
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 54, no. RR-14
    Description:
    The recommendations in this report were developed to broaden the spectrum of antimicrobial agents that are available for treatment and postexposure prophylaxis of pertussis. They include updated information on macrolide agents other than erythromycin...
    File Type:
    Filetype[PDF - 672.77 KB]